Thu, April 4, 2024
Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Roy Buchanan Upgraded (ANTX) to Buy and Held Target at $6 on, Apr 2nd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. to-buy-and-held-target-at-6-on-apr-2nd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Roy Buchanan of JMP Securities, Upgraded "AN2 Therapeutics, Inc." (ANTX) to Buy and Held Target at $6 on, Apr 2nd, 2024.

Roy has made no other calls on ANTX in the last 4 months.



There are 3 other peers that have a rating on ANTX. Out of the 3 peers that are also analyzing ANTX, all agree with Roy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Jones of "Oppenheimer" Reiterated at Hold on, Monday, April 1st, 2024
  • Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $7 on, Tuesday, February 13th, 2024
  • Liisa Bayko of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $7 on, Monday, February 12th, 2024

Publication Contributing Sources